Variant report
Variant | esv3443742 |
---|---|
Chromosome Location | chr5:28484695-28488493 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570109376 | chr5:28484696-28484697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185187001 | chr5:28484727-28484728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4535464 | chr5:28484791-28484792 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs568317422 | chr5:28484798-28484799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552094547 | chr5:28484821-28484822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4421119 | chr5:28484858-28484859 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs557103124 | chr5:28484888-28484889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189070485 | chr5:28484899-28484900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181590451 | chr5:28484953-28484954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185351231 | chr5:28485041-28485042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547995763 | chr5:28485048-28485049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577320812 | chr5:28485079-28485080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs55712512 | chr5:28485147-28485148 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs571581514 | chr5:28485188-28485189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113284561 | chr5:28485203-28485204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190115445 | chr5:28485293-28485294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180717815 | chr5:28485294-28485295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186115192 | chr5:28485325-28485326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530566022 | chr5:28485338-28485339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192279909 | chr5:28485346-28485347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184018868 | chr5:28485397-28485398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563796985 | chr5:28485447-28485448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35412569 | chr5:28485459-28485460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186040861 | chr5:28485484-28485485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537437303 | chr5:28485486-28485487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140674293 | chr5:28485497-28485498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190513849 | chr5:28485498-28485499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375517118 | chr5:28485517-28485518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143748649 | chr5:28485572-28485573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550843789 | chr5:28485712-28485713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201980320 | chr5:28485713-28485714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10612214 | chr5:28485724-28485725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs367581098 | chr5:28485734-28485735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4615310 | chr5:28485739-28485740 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs79130755 | chr5:28485744-28485745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151084144 | chr5:28485763-28485764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577382325 | chr5:28485765-28485766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183118921 | chr5:28485806-28485807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371457491 | chr5:28485858-28485859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187003796 | chr5:28485859-28485860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116223546 | chr5:28485913-28485914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563591222 | chr5:28485920-28485921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575441128 | chr5:28485931-28485932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545961360 | chr5:28485959-28485960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550201592 | chr5:28485970-28485971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192780025 | chr5:28485986-28485987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569991937 | chr5:28485989-28485990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543408874 | chr5:28486022-28486023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528175498 | chr5:28486037-28486038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538646563 | chr5:28486046-28486047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:28484000-28486400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:28484200-28488800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr5:28485400-28487000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr5:28486400-28486800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr5:28486600-28486800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr5:28486600-28487200 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr5:28486800-28487000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr5:28486800-28487400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr5:28487000-28487200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr5:28487000-28487800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr5:28487000-28487800 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr5:28487200-28487400 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr5:28487200-28488400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:28487200-28488600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr5:28487400-28488600 | Weak transcription | H9 Cell Line | embryonic stem cell |
16 | chr5:28487400-28489400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr5:28487600-28488000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr5:28487600-28488600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr5:28487800-28488800 | Weak transcription | H1 Cell Line | embryonic stem cell |
20 | chr5:28487800-28489800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr5:28488000-28489200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
22 | chr5:28488400-28488800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |